Neutralizing antibody titers elicited by CoronaVac and BNT162b2 vaccines in health care workers with and without prior SARS-CoV-2 infection
| Author | dc.contributor.author | Wolff Reyes, Marcelo José | |
| Author | dc.contributor.author | Acevedo Acevedo, Mónica Loreto | |
| Author | dc.contributor.author | Núñez, María Antonieta | |
| Author | dc.contributor.author | Lafourcade, Mónica | |
| Author | dc.contributor.author | Gaete Argel, Aracelly Janis | |
| Author | dc.contributor.author | Soto Rifo, Ricardo Andrés | |
| Author | dc.contributor.author | Valiente Echeverría, Fernando Andrés | |
| Admission date | dc.date.accessioned | 2022-12-14T14:35:52Z | |
| Available date | dc.date.available | 2022-12-14T14:35:52Z | |
| Publication date | dc.date.issued | 2022 | |
| Cita de ítem | dc.identifier.citation | Journal of Travel Medicine, 2022, 1–3 | es_ES |
| Identifier | dc.identifier.other | 10.1093/jtm/taac010 | |
| Identifier | dc.identifier.uri | https://repositorio.uchile.cl/handle/2250/189758 | |
| Abstract | dc.description.abstract | We report neutralizing antibody titers (NAbTs) elicited by CoronaVac and BNT162b2 vaccines in healthcare workers with and without prior SARS-CoV-2 infection using both a pseudotype-based assay and a commercial kit. NAbTs were higher for the mRNA vaccine and increased in all previously infected. Good correlation between both assays was found. | es_ES |
| Patrocinador | dc.description.sponsorship | ANID Chile through Fondecyt 1190156 1211547 | es_ES |
| Lenguage | dc.language.iso | en | es_ES |
| Publisher | dc.publisher | Oxford University Press | es_ES |
| Type of license | dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
| Link to License | dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
| Source | dc.source | Journal of Travel Medicine | es_ES |
| Keywords | dc.subject | COVID-19 (Enfermedad) | es_ES |
| Keywords | dc.subject | Vaccination | es_ES |
| Keywords | dc.subject | SARS-CoV-2 | es_ES |
| Keywords | dc.subject | CoronaVac | es_ES |
| Keywords | dc.subject | BNT162b2 | es_ES |
| Keywords | dc.subject | Anti-RBD kit | es_ES |
| Título | dc.title | Neutralizing antibody titers elicited by CoronaVac and BNT162b2 vaccines in health care workers with and without prior SARS-CoV-2 infection | es_ES |
| Document type | dc.type | Artículo de revista | es_ES |
| dc.description.version | dc.description.version | Versión publicada - versión final del editor | es_ES |
| dcterms.accessRights | dcterms.accessRights | Acceso abierto | es_ES |
| Cataloguer | uchile.catalogador | apc | es_ES |
| Indexation | uchile.index | Artículo de publícación WoS | es_ES |
Files in this item
This item appears in the following Collection(s)
-
Artículos de revistas
Artículos de revistas
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States